Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 101

1.

Lambert-Eaton myasthenic syndrome and merkel cell carcinoma.

Nguyen ND, Simmons DB, Bersabe AR, Duginski TM, Sladky JH, Walton D, Will M, Renshaw JS.

Cutis. 2019 May;103(5):E19-E23.

PMID:
31233589
2.

Animal Derived Thiol Induced Work Exacerbated Asthma: A Brief Case Report of a Unique Workplace Hazard.

Downs JW, Renshaw JM.

US Army Med Dep J. 2018 Jul-Dec;(2-18):84-86.

PMID:
30623404
3.

Versatile Poly(Diallyl Dimethyl Ammonium Chloride)-Layered Nanocomposites for Removal of Cesium in Water Purification.

Jang SC, Kang SM, Kim GY, Rethinasabapathy M, Haldorai Y, Lee I, Han YK, Renshaw JC, Roh C, Huh YS.

Materials (Basel). 2018 Jun 12;11(6). pii: E998. doi: 10.3390/ma11060998.

4.

Serious concerns about the General Dental Council's performance and its direction of travel.

Renshaw J.

Br Dent J. 2018 Feb 23;224(4):213-214. doi: 10.1038/sj.bdj.2018.80. Epub 2018 Feb 16.

PMID:
29449652
5.

IGF1R signalling in testicular germ cell tumour cells impacts on cell survival and acquired cisplatin resistance.

Selfe J, Goddard NC, McIntyre A, Taylor KR, Renshaw J, Popov SD, Thway K, Summersgill B, Huddart RA, Gilbert DC, Shipley JM.

J Pathol. 2018 Feb;244(2):242-253. doi: 10.1002/path.5008. Epub 2018 Jan 10.

6.

Identification and Characterization of Dual Inhibitors of the USP25/28 Deubiquitinating Enzyme Subfamily.

Wrigley JD, Gavory G, Simpson I, Preston M, Plant H, Bradley J, Goeppert AU, Rozycka E, Davies G, Walsh J, Valentine A, McClelland K, Odrzywol KE, Renshaw J, Boros J, Tart J, Leach L, Nowak T, Ward RA, Harrison T, Andrews DM.

ACS Chem Biol. 2017 Dec 15;12(12):3113-3125. doi: 10.1021/acschembio.7b00334. Epub 2017 Nov 28.

PMID:
29131570
7.

Structure and characterization of a high affinity C5a monoclonal antibody that blocks binding to C5aR1 and C5aR2 receptors.

Colley CS, Popovic B, Sridharan S, Debreczeni JE, Hargeaves D, Fung M, An LL, Edwards B, Arnold J, England E, Eghobamien L, Sivars U, Flavell L, Renshaw J, Wickson K, Warrener P, Zha J, Bonnell J, Woods R, Wilkinson T, Dobson C, Vaughan TJ.

MAbs. 2018 Jan;10(1):104-117. doi: 10.1080/19420862.2017.1384892. Epub 2017 Oct 24.

8.

Biogenic Hydroxyapatite: A New Material for the Preservation and Restoration of the Built Environment.

Turner RJ, Renshaw JC, Hamilton A.

ACS Appl Mater Interfaces. 2017 Sep 20;9(37):31401-31410. doi: 10.1021/acsami.7b07927. Epub 2017 Sep 5.

9.

Chronic Lymphocytic Leukemia as an Unusual Cause of Rapid Airway Compromise.

Bersabe AR, Romain JT, Ezzell EE, Renshaw JS.

Case Rep Oncol Med. 2017;2017:8247353. doi: 10.1155/2017/8247353. Epub 2017 Mar 15.

10.

Rates of Microbiologically Diagnosed Infection and Pathogen Detection in Hematopoietic Stem Cell Transplant Patients.

Lee LE, Barsoumian AE, Brown AW, Wiggins MA, Renshaw JS, Osswald MB, Murray CK.

Mil Med. 2016 Nov;181(11):e1685-e1691.

PMID:
27849508
11.

Effective combination therapies in preclinical endocrine resistant breast cancer models harboring ER mutations.

Ladd B, Mazzola AM, Bihani T, Lai Z, Bradford J, Collins M, Barry E, Goeppert AU, Weir HM, Hearne K, Renshaw JG, Mohseni M, Hurt E, Jalla S, Bao H, Hollingsworth R, Reimer C, Zinda M, Fawell S, D'Cruz CM.

Oncotarget. 2016 Aug 23;7(34):54120-54136. doi: 10.18632/oncotarget.10852.

12.

Inhibition of mTOR-kinase destabilizes MYCN and is a potential therapy for MYCN-dependent tumors.

Vaughan L, Clarke PA, Barker K, Chanthery Y, Gustafson CW, Tucker E, Renshaw J, Raynaud F, Li X, Burke R, Jamin Y, Robinson SP, Pearson A, Maira M, Weiss WA, Workman P, Chesler L.

Oncotarget. 2016 Sep 6;7(36):57525-57544. doi: 10.18632/oncotarget.10544.

13.

Can the British Heart Foundation PocketCPR application improve the performance of chest compressions during bystander resuscitation: A randomised crossover manikin study.

Eaton G, Renshaw J, Gregory P, Kilner T.

Health Informatics J. 2018 Mar;24(1):14-23. doi: 10.1177/1460458216652645. Epub 2016 Jul 11.

PMID:
27402135
14.

Backbone resonance assignments for the PHD-Bromo dual-domain of the human chromatin reader TRIM24.

Walser R, Renshaw J, Milbradt AG.

Biomol NMR Assign. 2016 Apr;10(1):207-11. doi: 10.1007/s12104-016-9668-9. Epub 2016 Feb 15.

PMID:
26878853
15.

Influence of riboflavin on the reduction of radionuclides by Shewanella oneidenis MR-1.

Cherkouk A, Law GT, Rizoulis A, Law K, Renshaw JC, Morris K, Livens FR, Lloyd JR.

Dalton Trans. 2016 Mar 28;45(12):5030-7. doi: 10.1039/c4dt02929a.

16.

Structure-Guided Design of Highly Selective and Potent Covalent Inhibitors of ERK1/2.

Ward RA, Colclough N, Challinor M, Debreczeni JE, Eckersley K, Fairley G, Feron L, Flemington V, Graham MA, Greenwood R, Hopcroft P, Howard TD, James M, Jones CD, Jones CR, Renshaw J, Roberts K, Snow L, Tonge M, Yeung K.

J Med Chem. 2015 Jun 11;58(11):4790-801. doi: 10.1021/acs.jmedchem.5b00466. Epub 2015 May 28.

PMID:
25977981
17.

Improved expression and purification of the Helicobacter pylori adhesin BabA through the incorporation of a hexa-lysine tag.

Hage N, Renshaw JG, Winkler GS, Gellert P, Stolnik S, Falcone FH.

Protein Expr Purif. 2015 Feb;106:25-30. doi: 10.1016/j.pep.2014.10.009. Epub 2014 Oct 25.

18.

Bacterially produced calcium phosphate nanobiominerals: sorption capacity, site preferences, and stability of captured radionuclides.

Handley-Sidhu S, Hriljac JA, Cuthbert MO, Renshaw JC, Pattrick RA, Charnock JM, Stolpe B, Lead JR, Baker S, Macaskie LE.

Environ Sci Technol. 2014 Jun 17;48(12):6891-8. doi: 10.1021/es500734n. Epub 2014 May 23.

PMID:
24823240
19.

Dentist suicides.

Renshaw J.

Br Dent J. 2013 Dec;215(11):593-4. doi: 10.1038/sj.bdj.2013.1144.

PMID:
24309807
20.

Dual blockade of the PI3K/AKT/mTOR (AZD8055) and RAS/MEK/ERK (AZD6244) pathways synergistically inhibits rhabdomyosarcoma cell growth in vitro and in vivo.

Renshaw J, Taylor KR, Bishop R, Valenti M, De Haven Brandon A, Gowan S, Eccles SA, Ruddle RR, Johnson LD, Raynaud FI, Selfe JL, Thway K, Pietsch T, Pearson AD, Shipley J.

Clin Cancer Res. 2013 Nov 1;19(21):5940-51. doi: 10.1158/1078-0432.CCR-13-0850. Epub 2013 Aug 5.

21.

Characterization of the complex formed between a potent neutralizing ovine-derived polyclonal anti-TNFα Fab fragment and human TNFα.

Abbott WM, Snow M, Eckersley S, Renshaw J, Davies G, Norman RA, Ceuppens P, Slootstra J, Benschop JJ, Hamuro Y, Lee JE, Newham P.

Biosci Rep. 2013 Aug 23;33(4). pii: e00060. doi: 10.1042/BSR20130044.

22.

Radiotolerance of phosphatases of a Serratia sp.: potential for the use of this organism in the biomineralization of wastes containing radionuclides.

Paterson-Beedle M, Jeong BC, Lee CH, Jee KY, Kim WH, Renshaw JC, Macaskie LE.

Biotechnol Bioeng. 2012 Aug;109(8):1937-46. doi: 10.1002/bit.24467. Epub 2012 Mar 15.

PMID:
22422344
23.

A new incorporation mechanism for trivalent actinides into bioapatite: a TRLFS and EXAFS study.

Holliday K, Handley-Sidhu S, Dardenne K, Renshaw J, Macaskie L, Walther C, Stumpf T.

Langmuir. 2012 Feb 28;28(8):3845-51. doi: 10.1021/la300014a. Epub 2012 Feb 16.

PMID:
22313032
24.

Negotiation: a necessary art for dental practice.

Fitzpatrick WG, Renshaw J, Batchelor P.

Prim Dent Care. 2012 Jan;19(1):29-33. doi: 10.1308/135576112798990818.

PMID:
22244491
25.

Antitumor activity of sustained N-myc reduction in rhabdomyosarcomas and transcriptional block by antigene therapy.

Tonelli R, McIntyre A, Camerin C, Walters ZS, Di Leo K, Selfe J, Purgato S, Missiaglia E, Tortori A, Renshaw J, Astolfi A, Taylor KR, Serravalle S, Bishop R, Nanni C, Valentijn LJ, Faccini A, Leuschner I, Formica S, Reis-Filho JS, Ambrosini V, Thway K, Franzoni M, Summersgill B, Marchelli R, Hrelia P, Cantelli-Forti G, Fanti S, Corradini R, Pession A, Shipley J.

Clin Cancer Res. 2012 Feb 1;18(3):796-807. doi: 10.1158/1078-0432.CCR-11-1981. Epub 2011 Nov 7.

26.

Impact of silver nanoparticles on natural marine biofilm bacteria.

Fabrega J, Zhang R, Renshaw JC, Liu WT, Lead JR.

Chemosphere. 2011 Oct;85(6):961-6. doi: 10.1016/j.chemosphere.2011.06.066. Epub 2011 Jul 22.

PMID:
21782209
27.

Uptake of Sr2+ and Co2+ into biogenic hydroxyapatite: implications for biomineral ion exchange synthesis.

Handley-Sidhu S, Renshaw JC, Moriyama S, Stolpe B, Mennan C, Bagheriasl S, Yong P, Stamboulis A, Paterson-Beedle M, Sasaki K, Pattrick RA, Lead JR, Macaskie LE.

Environ Sci Technol. 2011 Aug 15;45(16):6985-90. doi: 10.1021/es2015132. Epub 2011 Jul 13.

PMID:
21714547
28.

Summary of the oral health of adults in Yorkshire and Humber 2008.

Renshaw J.

Br Dent J. 2010 Sep 25;209(6):284-5. doi: 10.1038/sj.bdj.2010.848. No abstract available.

PMID:
20871554
29.

Nano-crystalline hydroxyapatite bio-mineral for the treatment of strontium from aqueous solutions.

Handley-Sidhu S, Renshaw JC, Yong P, Kerley R, Macaskie LE.

Biotechnol Lett. 2011 Jan;33(1):79-87. doi: 10.1007/s10529-010-0391-9. Epub 2010 Sep 8.

PMID:
20824306
30.

MDM4 binds ligands via a mechanism in which disordered regions become structured.

Sanchez MC, Renshaw JG, Davies G, Barlow PN, Vogtherr M.

FEBS Lett. 2010 Jul 16;584(14):3035-41. doi: 10.1016/j.febslet.2010.05.058. Epub 2010 May 31.

31.

Interactions of silver nanoparticles with Pseudomonas putida biofilms.

Fabrega J, Renshaw JC, Lead JR.

Environ Sci Technol. 2009 Dec 1;43(23):9004-9. doi: 10.1021/es901706j.

PMID:
19943680
32.

Silver nanoparticle impact on bacterial growth: effect of pH, concentration, and organic matter.

Fabrega J, Fawcett SR, Renshaw JC, Lead JR.

Environ Sci Technol. 2009 Oct 1;43(19):7285-90.

PMID:
19848135
33.

Growing disbelief.

Renshaw J, Crouch E, Gordon I, Batchelor P.

Br Dent J. 2009 Jul 11;207(1):3-4; author reply 4. doi: 10.1038/sj.bdj.2009.561. No abstract available.

PMID:
19590532
34.

Preliminary indications from atomic force microscopy of the presence of rapidly-formed nanoscale films on aquifer material surfaces.

Gaebel C, Lead JR, Renshaw JC, Tellam JH.

J Contam Hydrol. 2009 Aug 11;108(1-2):46-53. doi: 10.1016/j.jconhyd.2009.05.006. Epub 2009 May 19.

PMID:
19589614
35.

Validation of the L/S ratio determined by digital scanning densitometry.

Parnas ML, Renshaw J, Grenache DG.

Clin Chim Acta. 2009 Mar;401(1-2):177-8. doi: 10.1016/j.cca.2008.11.005. Epub 2008 Nov 13. No abstract available.

PMID:
19061878
36.

Formation of nanoscale elemental silver particles via enzymatic reduction by Geobacter sulfurreducens.

Law N, Ansari S, Livens FR, Renshaw JC, Lloyd JR.

Appl Environ Microbiol. 2008 Nov;74(22):7090-3. doi: 10.1128/AEM.01069-08. Epub 2008 Aug 22.

37.

Reduction of uranium(VI) phosphate during growth of the thermophilic bacterium Thermoterrabacterium ferrireducens.

Khijniak TV, Slobodkin AI, Coker V, Renshaw JC, Livens FR, Bonch-Osmolovskaya EA, Birkeland NK, Medvedeva-Lyalikova NN, Lloyd JR.

Appl Environ Microbiol. 2005 Oct;71(10):6423-6.

38.

After the first 125 years of the BDJ where might clinical dentistry be heading?

Renshaw J.

Br Dent J. 2005 Sep 24;199(6):331-7. No abstract available.

PMID:
16184104
39.

Bioreduction of uranium: environmental implications of a pentavalent intermediate.

Renshaw JC, Butchins LJ, Livens FR, May I, Charnock JM, Lloyd JR.

Environ Sci Technol. 2005 Aug 1;39(15):5657-60.

PMID:
16124300
40.

Microbial transformations of radionuclides: fundamental mechanisms and biogeochemical implications.

Lloyd JR, Renshaw JC.

Met Ions Biol Syst. 2005;44:205-40. Review. No abstract available.

PMID:
15971669
41.

Bioremediation of radioactive waste: radionuclide-microbe interactions in laboratory and field-scale studies.

Lloyd JR, Renshaw JC.

Curr Opin Biotechnol. 2005 Jun;16(3):254-60. Review.

PMID:
15916892
42.

Disruption of WT1 gene expression and exon 5 splicing following cytotoxic drug treatment: antisense down-regulation of exon 5 alters target gene expression and inhibits cell survival.

Renshaw J, Orr RM, Walton MI, Te Poele R, Williams RD, Wancewicz EV, Monia BP, Workman P, Pritchard-Jones K.

Mol Cancer Ther. 2004 Nov;3(11):1467-84.

43.

Spectroscopic evidence for the direct coordination of the pertechnetate anion to the uranyl cation in [UO2(TcO4)(DPPMO2)2]+.

Sutton AD, John GH, Sarsfield MJ, Renshaw JC, May I, Martin LR, Selvage AJ, Collison D, Helliwell M.

Inorg Chem. 2004 Sep 6;43(18):5480-2.

PMID:
15332793
44.

Why we must keep on talking.

Renshaw J.

Br Dent J. 2003 Dec 6;195(11):617. No abstract available.

PMID:
14718986
45.

Rhodotorulic acid production by Rhodotorula mucilaginosa.

Andersen D, Renshaw JC, Wiebe MG.

Mycol Res. 2003 Aug;107(Pt 8):949-56.

PMID:
14531617
46.

Development and application of an assay for uranyl complexation by fungal metabolites, including siderophores.

Renshaw JC, Halliday V, Robson GD, Trinci AP, Wiebe MG, Livens FR, Collison D, Taylor RJ.

Appl Environ Microbiol. 2003 Jun;69(6):3600-6.

47.

Solution chemistry of uranyl ion with iminodiacetate and oxydiacetate: A combined NMR/EXAFS and potentiometry/calorimetry study.

Jiang J, Renshaw JC, Sarsfield MJ, Livens FR, Collison D, Charnock JM, Eccles H.

Inorg Chem. 2003 Feb 24;42(4):1233-40.

PMID:
12588161
48.

A delicate balance.

Renshaw J.

Br Dent J. 2002 Sep 14;193(5):241. No abstract available.

49.

Synthesis and characterization of uranyl compounds with iminodiacetate and oxydiacetate displaying variable denticity.

Jiang J, Sarsfield MJ, Renshaw JC, Livens FR, Collison D, Charnock JM, Helliwell M, Eccles H.

Inorg Chem. 2002 May 20;41(10):2799-806.

PMID:
12005506
50.

Cochlear implantation in auditory neuropathy.

Miyamoto RT, Kirk KI, Renshaw J, Hussain D, Seghal ST.

Adv Otorhinolaryngol. 2000;57:160-1. No abstract available.

PMID:
11892135

Supplemental Content

Loading ...
Support Center